Literature DB >> 22549394

The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.

Mustapha Kandouz1.   

Abstract

Cancer cells rely on intercellular communication throughout the different stages of their transformation and progression into metastasis. They do so by co-opting different processes such as cell-cell junctions, growth factors, receptors, and vesicular release. Initially characterized in neuronal and vascular tissues, Ephs and Ephrins, the largest family of receptor tyrosine kinases, comprised of two classes (i.e., A and B types), is increasingly scrutinized by cancer researchers. These proteins possess the particular features of both the receptors and ligands being membrane-bound which, via mandatory direct cell-cell interactions, undergo a bidirectional signal transduction initiated from both the receptor and the ligand. Following cell-cell interactions, Ephs/Ephrins behave as guidance molecules which trigger both repulsive and attractive signals, so as to direct the movement of cells through their immediate microenvironment. They also direct processes which include sorting and positioning and cytoskeleton rearrangements, thus making them perfect candidates for the control of the metastatic process. In fact, the role of Ephs and Ephrins in cancer progression has been demonstrated for many of the family members and they, surprisingly, have both tumor promoter and suppressor functions in different cellular contexts. They are also able to coordinate between multiple processes including cell survival, proliferation, differentiation, adhesion, motility, and invasion. This review is an attempt to summarize the data available on these Ephs/Ephrins' biological functions which contribute to the onset of aggressive cancers. I will also provide an overview of the factors which could explain the functional differences demonstrated by Ephs and Ephrins at different stages of tumor progression and whose elucidation is warranted for any future therapeutic targeting of this signaling pathway in cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549394     DOI: 10.1007/s10555-012-9352-1

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  33 in total

1.  Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.

Authors:  Shuigen Zhou; Longxin Wang; Guimei Li; Zhengyu Zhang; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells.

Authors:  Priscila Guimarães de Marcondes; Lilian Gonçalves Bastos; Julio Cesar Madureira de-Freitas-Junior; Murilo Ramos Rocha; José Andrés Morgado-Díaz
Journal:  Tumour Biol       Date:  2016-06-21

3.  A Cell-Surface Membrane Protein Signature for Glioblastoma.

Authors:  Dhimankrishna Ghosh; Cory C Funk; Juan Caballero; Nameeta Shah; Katherine Rouleau; John C Earls; Liliana Soroceanu; Greg Foltz; Charles S Cobbs; Nathan D Price; Leroy Hood
Journal:  Cell Syst       Date:  2017-03-29       Impact factor: 10.304

Review 4.  Cell mates: paracrine and stromal targets for prostate cancer therapy.

Authors:  Pavel Sluka; Ian D Davis
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

5.  Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.

Authors:  Buyong Ma; Stephanie Kolb; Michael Diprima; Molleshree Karna; Giovanna Tosato; Qiqi Yang; Qiang Huang; Ruth Nussinov
Journal:  Growth Factors       Date:  2014-11-20       Impact factor: 2.511

6.  IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases.

Authors:  R Alejandro Márquez-Ortiz; Maria J Contreras-Zárate; Vesna Tesic; Karen L F Alvarez-Eraso; Gina Kwak; Zachary Littrell; James C Costello; Varsha Sreekanth; D Ryan Ormond; Sana D Karam; Peter Kabos; Diana M Cittelly
Journal:  Clin Cancer Res       Date:  2021-09-20       Impact factor: 12.531

7.  The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer.

Authors:  Ryan M Johnson; Ngoc T Vu; Brian P Griffin; Amanda E Gentry; Kellie J Archer; Charles E Chalfant; Margaret A Park
Journal:  J Biol Chem       Date:  2015-08-24       Impact factor: 5.157

8.  Promiscuous and specific recognition among ephrins and Eph receptors.

Authors:  Dandan Dai; Qiang Huang; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta       Date:  2014-07-10

9.  EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activation.

Authors:  Hee Jun Cho; Yoo-Seok Hwang; Kathleen Mood; Yon Ju Ji; Junghwa Lim; Deborah K Morrison; Ira O Daar
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

10.  Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.

Authors:  Ben Davidson; Vera Maria Abeler; Ellen Hellesylt; Arild Holth; Ie-Ming Shih; Tone Skeie-Jensen; Li Chen; Yanqin Yang; Tian-Li Wang
Journal:  Gynecol Oncol       Date:  2012-11-21       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.